Cardinal Health, Inc. $CAH Shares Sold by Cinctive Capital Management LP

Key Points

• Cinctive Capital Management LP sold 89,556 shares of Cardinal Health, reducing its position by 62.1% during the 1st quarter, leaving them with 54,566 shares valued at approximately $7.5 million.
• Cardinal Health reported $2.08 earnings per share (EPS) for the last quarter, exceeding analyst expectations of $2.03, and has set FY 2026 guidance at 9.300-9.500 EPS.
• The firm declared a quarterly dividend of $0.5107 per share, resulting in an annualized dividend of $2.04 and a yield of 1.4% for investors of record on October 1st.

Cinctive Capital Management LP lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 62.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,566 shares of the company's stock after selling 89,556 shares during the period. Cinctive Capital Management LP's holdings in Cardinal Health were worth $7,518,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CAH. Greykasell Wealth Strategies Inc. bought a new position in shares of Cardinal Health during the first quarter valued at $26,000. Tompkins Financial Corp lifted its stake in Cardinal Health by 106.7% during the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after acquiring an additional 128 shares during the period. GW&K Investment Management LLC boosted its holdings in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after acquiring an additional 144 shares during the last quarter. Measured Risk Portfolios Inc. bought a new stake in shares of Cardinal Health in the fourth quarter worth approximately $47,000. Finally, NBC Securities Inc. purchased a new position in shares of Cardinal Health during the first quarter valued at approximately $48,000. 87.17% of the stock is owned by institutional investors.

Insider Activity

In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares in the company, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jessica L. Mayer sold 38,078 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider owned 48,457 shares in the company, valued at $7,211,370.74. The trade was a 44.00% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 271,676 shares of company stock worth $40,489,525. Company insiders own 0.09% of the company's stock.

Cardinal Health Price Performance

Shares of CAH stock traded up $1.17 during mid-day trading on Tuesday, hitting $151.45. The stock had a trading volume of 534,953 shares, compared to its average volume of 2,407,861. The firm's 50-day moving average is $155.51 and its two-hundred day moving average is $147.27. The firm has a market capitalization of $36.16 billion, a P/E ratio of 23.47, a price-to-earnings-growth ratio of 1.26 and a beta of 0.73. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business's revenue was up .5% compared to the same quarter last year. During the same period last year, the business posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health's dividend payout ratio is presently 31.63%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CAH shares. Leerink Partners cut their target price on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research report on Tuesday, August 12th. Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a report on Tuesday, August 12th. Bank of America boosted their price target on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Finally, Evercore ISI reduced their target price on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.